Business & Consumer Services » Consumer Services | Blake Insomnia Therapeutics Inc.

Blake Insomnia Therapeutics Inc.

Blake Insomnia Therapeutics Inc.
Stock Exchange Other OTC
EPS
$1.53
Market Cap
$46.56 M
Shares Outstanding
25.03 M
Public Float
15 K

Profile

Address
244 5th Avenue
New York New York 10001
United States
Employees -
Website http://www.blakeinsomnia.com
Updated 07/08/2019
Blake Insomnia Therapeutics, Inc. operates as a pharmaceutical company, which provides insomnia remedy. The firm has developed Zleepax, which is a sleep aid with beta blockers as the major active agent. The company was founded by Briger Jan Olsen on August 11, 2012 and is headquartered in New York, NY.

Financials

View All

Daniel Cattlin
President, CEO, CFO, Secretary & Treasurer
Daniel Cattlin
President, CEO, CFO, Secretary & Treasurer